Risk Factors for Shoulder Joint Motion Restriction
1 other identifier
observational
72
1 country
1
Brief Summary
In breast cancer patients, limitation of shoulder joint movement may occur following cancer treatment. Shoulder limitation causes a significant decrease in the patient's participation in activities of daily living. The aim of the study is to define these limitations, to evaluate in detail all the structures that cause the problem, and to determine the causes of the limitations in patients with shoulder joint movement limitation developed after breast cancer survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 18, 2022
CompletedFirst Posted
Study publicly available on registry
May 23, 2022
CompletedStudy Start
First participant enrolled
August 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2024
CompletedMay 31, 2022
May 1, 2022
1 year
May 18, 2022
May 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
measurement of tissue stiffness (N/m)
Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain
Baseline
measurement of passive muscle tone (Hz)
muscle tones will be measured with myotonPro on centers of coordination located along the myofascial chain
Baseline
measurement of creep of tissue
creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain
Baseline
measurement of the range of shoulder joint motion
The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.
Baseline
Secondary Outcomes (4)
measurement of skin temperature
Baseline
measurement of pain
Baseline
measurement of pain pressure threshold
Baseline
measurement of grip strength
Baseline
Study Arms (2)
Experimental Group
Breast cancer survivors with shoulder joint motion restriction
Control group
Breast cancer survivors without shoulder joint motion restriction
Interventions
Stiffness values will be measured with myotonPro on centers of coordination located along the myofascial chain
muscle tones will be measured with myotonPro on centers of coordination located along along the myofascial chain
creep of tissue will be measured with myotonPro on centers of coordination located along the myofascial chain
The range of shoulder flexion, abduction, extension and external-internal rotation movements will be measured with a universal goniometer.
measurements will be taken by the thermographic camera
Pain will be evaluated by visual analog scale (VAS)
Pain pressure threshold will be evaluated by a digital algometer
The grip strength of both hand will be evaluated by "hand-held" dynamometer.
Eligibility Criteria
Breast cancer survivors with or without shoulder joint restriction will be evaluated
You may qualify if:
- Women between the ages of 30-60
- Having breast cancer treatment within 5 years
You may not qualify if:
- Not having agreed to participate in the study
- Presence of additional orthopedic (scoliosis, etc.), neurological (multiple sclerosis, stroke, etc.) and rheumatological diseases (ankylosing spondylitis, rheumatoid arthritis, etc.) that will affect upper extremity functions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
İstanbul Medeniyet University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 18, 2022
First Posted
May 23, 2022
Study Start
August 15, 2022
Primary Completion
August 15, 2023
Study Completion
February 15, 2024
Last Updated
May 31, 2022
Record last verified: 2022-05